Loading...
The North American Menopause Society (NAMS) has released an updated position statement that addresses a common consequence of estrogen loss in menopausal women: vulvovaginal atrophy (VVA). Almost half of postmenopausal women have reported experiencing vaginal symptoms including dryness, irritation, and pain with intercourse, but very few understand the relation of these symptoms to menopause or discuss them with a healthcare provider. The NAMS statement includes information about the evaluation, diagnosis, and treatment of VVA.
Highlights of the recommendations are as follows:
First-line treatments for symptomatic VVA include lubricants and long-acting vaginal moisturizers.
For persistent or moderate-to-severe VVA, low-dose vaginal or systemic…